Engineered clearing agents for the selective depletion of antigen-specific antibodies

被引：33

作者：

Devanaboyina, Siva Charan ^{[1
,2
]}

Khare, Priyanka ^{[1
,2
]}

Challa, Dilip K. ^{[1
,2
]}

Ober, Raimund J. ^{[1
,3
]}

Ward, E. Sally ^{[1
,2
]}

机构：

[1] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, 469 Joe H Reynolds Med Sci Bldg,1114 TAMU, College Stn, TX 77843 USA

[2] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, 3107 Med Res & Educ Bldg,8447 State Highway 47, Bryan, TX 77807 USA

[3] Texas A&M Univ, Dept Biomed Engn, 5045 Emerging Technol Bldg,3120 TAMU, College Stn, TX 77843 USA

来源：

NATURE COMMUNICATIONS | 2017年 / 8卷

关键词：

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEONATAL FC-RECEPTOR; I-RELATED RECEPTOR; MULTIPLE-SCLEROSIS; NONHUMAN-PRIMATES; IGG; AUTOIMMUNE; REDUCTION; BLOCKADE; DELIVERY;

D O I：

10.1038/ncomms15314

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Here we have designed a novel class of engineered antibody-based reagents ('Seldegs') that induce the selective degradation of antigen-specific antibodies. We demonstrate the rapid and specific clearance of antibodies recognizing the autoantigen, myelin oligodendrocyte glycoprotein and tumour target, HER2. Seldegs have considerable potential in multiple areas, including the treatment of antibody-mediated autoimmunity and diagnostic imaging.

引用

页数：6

共 26 条

[1] The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed toward Multiple Epitopes in C57BL/6-Immunized Mice
Bansal, Pankaj
Khan, Tarique
Bussmeyer, Uta
Challa, Dilip K.
Swiercz, Rafal
Velmurugan, Ramraj
Ober, Raimund J.
Ward, E. Sally
[J]. JOURNAL OF IMMUNOLOGY, 2013, 191 (03) : 1091 - 1101
[2] Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway
Bitonti, AJ
Dumont, JA
Low, SC
Peters, RT
Kropp, KE
Palombella, VJ
Stattel, JM
Lu, YC
Tan, CA
Song, JJ
Garcia, AM
Simister, NE
Spiekermann, GM
Lencer, WI
Blumberg, RS
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9763 - 9768
[3] Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents
Breithaupt, Constanze
Schaefer, Beatrix
Pellkofer, Hannah
Huber, Robert
Linington, Christopher
Jacob, Uwe
[J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (02) : 1255 - 1263
[4] Potent antibody therapeutics by design
Carter, PJ
[J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (05) : 343 - 357
[5] Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
Chu, Seung Y.
Horton, Holly M.
Pong, Erik
Leung, Irene W. L.
Chen, Hsing
Duc-Hanh Nguyen
Bautista, Cristina
Muchhal, Umesh S.
Bernett, Matthew J.
Moore, Gregory L.
Szymkowski, David E.
Desjarlais, John R.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (04) : 1102 - 1115
[6] Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
Dall'Acqua, WF
Woods, RM
Ward, ES
Palaszynski, SR
Patel, NK
Brewah, YA
Wu, H
Kiener, PA
Langermann, S
[J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (09) : 5171 - 5180
[7] Analyses of the Recycling Receptor, FcRn, in Live Cells Reveal Novel Pathways for Lysosomal Delivery
Gan, Zhuo
Ram, Sripad
Vaccaro, Carlos
Ober, Raimund J.
Ward, E. Sally
[J]. TRAFFIC, 2009, 10 (05) : 600 - 614
[8] Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions
Getman, KE
Balthasar, JP
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (04) : 718 - 729
[9] ENGINEERING HYBRID GENES WITHOUT THE USE OF RESTRICTION ENZYMES - GENE-SPLICING BY OVERLAP EXTENSION
HORTON, RM
HUNT, HD
HO, SN
PULLEN, JK
PEASE, LR
[J]. GENE, 1989, 77 (01) : 61 - 68
[10] Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
Igawa, Tomoyuki
Haraya, Kenta
Hattori, Kunihiro
[J]. IMMUNOLOGICAL REVIEWS, 2016, 270 (01) : 132 - 151

← 1 2 3 →